Oncology Institute (TOI) Competitors $4.75 +0.14 (+3.04%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$4.78 +0.04 (+0.74%) As of 10/24/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. AHCO, FTRE, PNTG, PSNL, CDNA, INNV, FLGT, CSTL, AIRS, and AUNAShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include AdaptHealth (AHCO), Fortrea (FTRE), The Pennant Group (PNTG), Personalis (PSNL), CareDx (CDNA), InnovAge (INNV), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), AirSculpt Technologies (AIRS), and Auna (AUNA). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors AdaptHealth Fortrea The Pennant Group Personalis CareDx InnovAge Fulgent Genetics Castle Biosciences AirSculpt Technologies Auna Oncology Institute (NASDAQ:TOI) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk. Do analysts prefer TOI or AHCO? Oncology Institute presently has a consensus price target of $7.00, indicating a potential upside of 47.37%. AdaptHealth has a consensus price target of $13.40, indicating a potential upside of 43.01%. Given Oncology Institute's stronger consensus rating and higher probable upside, equities research analysts plainly believe Oncology Institute is more favorable than AdaptHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75AdaptHealth 2 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.43 Which has more volatility & risk, TOI or AHCO? Oncology Institute has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Which has preferable earnings & valuation, TOI or AHCO? AdaptHealth has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$393.41M1.13-$64.66M-$0.68-6.99AdaptHealth$3.26B0.39$90.42M$0.5417.35 Is TOI or AHCO more profitable? AdaptHealth has a net margin of 2.49% compared to Oncology Institute's net margin of -14.26%. AdaptHealth's return on equity of 5.01% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-14.26% -1,527.21% -34.25% AdaptHealth 2.49%5.01%1.77% Does the media refer more to TOI or AHCO? In the previous week, Oncology Institute had 3 more articles in the media than AdaptHealth. MarketBeat recorded 8 mentions for Oncology Institute and 5 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.58 beat Oncology Institute's score of 0.57 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in TOI or AHCO? 36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Comparatively, 1.6% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryAdaptHealth beats Oncology Institute on 11 of the 17 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$431.06M$8.46B$6.23B$10.67BDividend YieldN/A2.12%5.71%4.82%P/E Ratio-6.9979.4730.0930.16Price / Sales1.1342.77592.86133.57Price / CashN/A21.6037.0161.44Price / Book95.007.8412.046.60Net Income-$64.66M$250.93M$3.32B$276.82M7 Day Performance24.35%3.31%1.88%2.58%1 Month Performance34.94%1.90%7.68%3.76%1 Year Performance1,379.75%18.01%56.01%33.84% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.6431 of 5 stars$4.75+3.0%$7.00+47.4%+1,348.2%$431.06M$393.41M-6.99660News CoverageAnalyst ForecastOptions VolumeGap UpAHCOAdaptHealth3.5641 of 5 stars$9.47+3.6%$13.40+41.5%-11.3%$1.24B$3.26B17.5410,500News CoverageAnalyst ForecastFTREFortrea3.2766 of 5 stars$10.42+10.3%$12.39+18.9%-34.9%$858.06M$2.70B-0.9215,500PNTGThe Pennant Group3.8753 of 5 stars$24.00+1.5%$34.40+43.3%-24.2%$817.04M$695.24M30.777,000News CoverageAnalyst ForecastShort Interest ↑PSNLPersonalis2.9536 of 5 stars$10.12+10.8%$7.42-26.7%+106.0%$809.62M$84.61M-7.91400Analyst ForecastHigh Trading VolumeCDNACareDx4.4746 of 5 stars$15.22+5.6%$25.50+67.5%-34.5%$767M$333.79M14.92740News CoverageAnalyst ForecastGap UpINNVInnovAge0.7293 of 5 stars$5.35+0.2%$5.00-6.5%-9.1%$723.63M$853.70M-23.262,440Gap UpFLGTFulgent Genetics3.7804 of 5 stars$23.84+5.1%$25.33+6.3%+24.0%$694.21M$283.47M-14.361,313CSTLCastle Biosciences3.4898 of 5 stars$23.01+3.9%$36.57+58.9%-22.9%$642.24M$332.07M-65.74540News CoverageAIRSAirSculpt Technologies0.2994 of 5 stars$10.33+13.3%$3.75-63.7%+103.4%$569.43M$165.11M-41.32240Gap UpAUNAAuna4.2054 of 5 stars$6.30-0.2%$10.70+69.8%-12.7%$467.02M$1.17B7.1614,842 Related Companies and Tools Related Companies AdaptHealth Alternatives Fortrea Alternatives The Pennant Group Alternatives Personalis Alternatives CareDx Alternatives InnovAge Alternatives Fulgent Genetics Alternatives Castle Biosciences Alternatives AirSculpt Technologies Alternatives Auna Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
